Ali Behbahani of Littleton, CO appears across SEC filings — Form ADV advisers, Form D, Reg A, and crowdfunding offerings. Ali Behbahani appears on 26 filing roles across Form D (25), Form ADV (1).
| Filed | Source | Entity | Role | Location |
|---|---|---|---|---|
| 2025-03-31 | Form ADV | GOODFINCH MANAGEMENT, LLC | MANAGER | SAN FRANCISCO, CA |
| 2016-08-09 | Form D | ROTATION MEDICAL INC | Director | PLYMOUTH, MN |
| 2020-05-26 | Form D | MINERVA SURGICAL INC | Director | Santa Clara, CA |
| 2020-08-03 | Form D | GENOCEA BIOSCIENCES, INC. | Director | CAMBRIDGE, MA |
| 2017-01-23 | Form D | Ivantis, Inc. | Director | IRVINE, CA |
| 2014-03-18 | Form D | Oculeve, Inc. | Director | SAN FRANCISCO, CA |
| 2014-10-02 | Form D | Adaptimmune Ltd | Director | ABINGDON, OXFORDSHIRE, X0 |
| 2021-10-04 | Form D | Cardionomic, Inc. | Director | New Brighton, MN |
| 2020-04-10 | Form D | CRISPR Therapeutics AG | Director | Zug, V6 |
| 2019-03-01 | Form D | New Enterprise Associates 17, L.P. | Executive Officer | TIMONIUM, MD |
| 2025-06-05 | Form D | SpyGlassPharma, Inc. | Director | ALISO VIEJO, CA |
| 2019-09-06 | Form D | Nkarta, Inc. | Director | SOUTH SAN FRANCISCO, CA |
| 2023-02-06 | Form D | Arcellx, Inc. | Director | GAITHERSBURG, MD |
| 2019-12-19 | Form D | NEA BH SPV, L.P. | Executive Officer | TIMONIUM, MD |
| 2024-07-11 | Form D | 858 Therapeutics, Inc. | Director | SAN DIEGO, CA |
| 2021-03-24 | Form D | Monte Rosa Therapeutics, Inc. | Director | BOSTON, MA |
| 2020-09-04 | Form D | NEA BH SPV II, L.P. | Executive Officer | TIMONIUM, MD |
| 2022-04-22 | Form D | FirstLight Bio, Inc. | Director | NEW YORK, NY |
| 2022-12-30 | Form D | Launchpad Therapeutics, Inc. | Director | CAMBRIDGE, MA |
| 2026-03-27 | Form D | Nexo Therapeutics, Inc. | Related Person | LITTLETON, CO |
| 2025-06-25 | Form D | NEA SH SPV, L.P. | Executive Officer | TIMONIUM, MD |
| 2024-02-23 | Form D | NEA RP SPV, L.P. | Executive Officer | TIMONIUM, MD |
| 2024-08-02 | Form D | NEA TS 2024 SPV, L.P. | Executive Officer | TIMONIUM, MD |
| 2024-05-21 | Form D | NEA CH SPV, L.P. | Executive Officer | TIMONIUM, MD |
| 2024-07-18 | Form D | NEA Secondary Opportunity Fund, L.P. | Executive Officer | TIMONIUM, MD |
| 2025-01-24 | Form D | Tune Therapeutics, Inc. | Director | SEATTLE, WA |